TATA Health International Holdings Limited reported no changes to its capital structure for the month ended 31 July 2026, according to the monthly return filed with Hong Kong Exchanges and Clearing Limited on 05 August 2026.

Authorised share capital stood at 500.00 million ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 5.00 million. The authorised figure was unchanged from the previous month.

Issued share capital was steady at 242.85 million ordinary shares, with no treasury shares held. The company recorded no share issuances, cancellations, repurchases, or movements under options, warrants, convertibles, or other equity-linked instruments during the period.

TATA Health confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25% of issued shares as of the end of July 2026.

The monthly return was signed by Director Zhang Ming Qi, reflecting compliance with all relevant disclosure obligations under the Hong Kong Listing Rules.